Patient Care & Safety Standards Flashcards

A nurse administers a medication to a patient and then discovers the pharmacy dispensed the wrong concentration. The patient shows no immediate adverse effects. According to DHA patient safety standards, what is the MOST critical immediate action after ensuring patient stability?

Answer: Complete a mandatory incident report through the DHA-mandated adverse event reporting system and notify the immediate supervisor

DHA standards require immediate completion of an incident/adverse event report through the facility's official reporting system (aligned with DHA Patient Safety framework) and notification of the supervisor. This triggers the root cause analysis process and ensures systemic correction. Notifying only the physician or delaying to contact pharmacy first violates mandatory reporting timelines. Family notification follows a structured disclosure process, not as the first step.

During a surgical time-out in a DHA-accredited facility, the circulating nurse notices the operative site marking is absent on a patient scheduled for a right nephrectomy. The surgeon states he remembers which side from the pre-op assessment. What is the correct course of action?

Answer: Halt the procedure until the site is marked according to the Universal Protocol, even if it delays the surgical schedule

DHA's Universal Protocol (aligned with Joint Commission International standards adopted by DHA) mandates that the procedure be halted if site marking is absent for procedures requiring it. Verbal confirmation alone — even by multiple team members — does not substitute for physical site marking. The time-out must be completed correctly regardless of scheduling impact. Relying on imaging review or anesthesiologist confirmation without physical marking does not meet the protocol requirement.

A DHA-licensed facility implements a Failure Mode and Effects Analysis (FMEA) for its medication dispensing process. Which scenario BEST represents the proactive intent of FMEA within the DHA patient safety framework?

Answer: Mapping potential failure points in a newly proposed electronic dispensing system before it is deployed

FMEA is a prospective (proactive) risk assessment tool used to identify potential failure modes before they cause harm. Analyzing past errors describes a Root Cause Analysis (RCA), which is reactive. Staff surveys assess competency gaps, not process failure modes. Benchmarking sentinel events is useful for learning but is retrospective. Mapping failure points in a system before deployment is the definitive proactive application of FMEA.

A patient with a documented penicillin allergy (anaphylaxis) is prescribed cefazolin prophylactically before an orthopedic procedure. The prescribing physician argues that cross-reactivity rates are low (<2%) and the benefit outweighs the risk. Under DHA standards, what is the nurse's most appropriate response?

Answer: Refuse to administer the drug, document the refusal, and report the prescription to the charge nurse and pharmacy for clinical review

DHA standards support nurses' professional and ethical right — and duty — to refuse administration of a medication that poses a patient safety risk and to escalate through appropriate channels. While cross-reactivity between penicillins and cephalosporins is debated scientifically, a documented anaphylaxis to penicillin is a high-risk red flag requiring formal clinical review (pharmacist, physician, possibly allergy consult) before administration — not unilateral nurse administration or a nurse-administered test dose. Contacting family does not address the immediate clinical decision.

In a DHA-regulated ICU, a patient is on continuous renal replacement therapy (CRRT). During handover, the oncoming nurse notes the anticoagulation (heparin) rate was not documented for the last 2 hours on the flow sheet, though it is running. The offgoing nurse verbally confirms she ran it at the prescribed rate throughout. What is the MOST appropriate action aligned with DHA patient safety and documentation standards?

Answer: Document the discrepancy accurately with current timestamp, escalate to the charge nurse, and complete a variance report

DHA standards and international healthcare documentation ethics strictly prohibit backdating records, which constitutes falsification. Accepting verbal confirmation without documentation leaves a legally and clinically incomplete record. Pausing CRRT is not clinically indicated and could harm the patient. The correct action is to document the current status accurately with a real-time timestamp, transparently note the gap, escalate to the charge nurse for awareness, and file a variance/incident report — preserving accuracy and triggering systemic review without interrupting care.

A DHA facility's patient safety committee reviews data showing a 40% rate of pressure injury development in post-cardiac surgery patients despite standard prevention bundles. A proposed intervention involves implementing continuous bedside skin monitoring technology. Under the DHA patient safety improvement cycle, which step must occur BEFORE piloting this technology?

Answer: Conducting a Plan-Do-Study-Act (PDSA) cycle design including measurable objectives and a defined pilot population

DHA's quality and patient safety improvement framework is grounded in the PDSA (Plan-Do-Study-Act) improvement methodology. Before piloting any intervention, the 'Plan' phase requires defining clear objectives, identifying a test population, establishing measurable success criteria, and outlining the study design. Full facility-wide rollout before a pilot contradicts evidence-based improvement science. DHA does not require central pre-approval for internal quality improvement pilots (as opposed to clinical trials). Publication is not a prerequisite for implementing evidence-based improvement projects.